ATEN vs SHLS

The Advanced Deterministic Scorecard reveals a mixed financial profile for ATEN, with a Piotroski F-Score of 4/9 indicating borderline financial health and no available Altman Z-Score to assess bankruptcy risk. Despite solid profitability metrics—such as a 79.66% gross margin, 23.88% ROE, and consistent earnings surprises—the stock trades at a premium valuation (P/E 25.19 vs. sector avg 87.63) while exhibiting weak earnings growth (YoY -0.30%) and bearish insider activity. The current price of $17.38 is significantly above both the Graham Number ($6.68) and intrinsic value estimate ($4.83), suggesting overvaluation unless growth accelerates. Technical trend is bearish, and recent price performance has underperformed over the past year (-9.5%), offsetting strong long-term earnings execution and sector-relative resilience.

SHLS exhibits a concerning fundamental health profile with a Piotroski F-Score of 3/9, indicating weak financial strength. While the company shows impressive top-line growth (38.6% YoY) and an attractive PEG ratio of 0.70, the current price of $7.16 trades at a premium to both its Graham Number ($4.02) and Intrinsic Value ($5.90). The disconnect between strong growth metrics and a deteriorating health score, coupled with consistent earnings misses in recent quarters, suggests a high-risk growth play rather than a stable value investment.